Custom crystal tombstone celebrating a second close of Series A financing for Fusion Pharmaceuticals. The Hamilton, Ontario-based firm is focused on radiotherapeutics for treating cancer.
(8ALJ479)Custom crystal tombstone celebrating a second close of Series A financing for Fusion Pharmaceuticals. The Hamilton, Ontario-based firm is focused on radiotherapeutics for treating cancer.
(8ALJ479)Custom crystal tombstone marking a private placement by Swiss biopharmaceutical company Auris Medical. Ladenburg Thalmann acted as exclusive placement agent.
(8AMF064)Pyramid-shaped deal toy commemorating convertible notes issued by Ligand Pharmaceuticals, based in San Diego. Goldman Sachs and Barclays acted as Joint Book-Running Managers for the issue.
(8ALJ247)Custom crystal commemorating a research collaboration involving Neurocrine Biosciences and Jnana Therapeutics. The research centers on finding new small-molecule therapeutics targeting central nervous system disorders.
(8ALJ498)Star-shaped crystal deal toy recognizing the sale by TPG Growth of NorthStar Anesthesia, based in Irving, Texas.
(8ALJ313)Custom deal toy, incorporating a map of Costa Rica, commemorating the initial public offering (IPO) by Establishment Labs. Med-tech firm is the first Costa Rican company to go public on the American Stock Exchange.
(8AJH238)Custom crystal deal toy commemorating a follow-on offering by EnteroMedics. Ladenburg Thalmann acted as sole bookrunning manager for the follow-on issue by the medical device developer. Based in St. Paul, Minnesota, the company was renamed ReShape Lifesciences in October 2017.
(7AMF287)